The present invention relates to compounds which modulate the activity of the S1P1 receptor, the use of these compounds for treating conditions associated with signaling through the S1P1 receptor, and pharmaceutical compositions comprising these compounds.

 
Web www.patentalert.com

< Method of treatment or prophylaxis

< Methods and compositions for treating amyloid-related diseases

> Cancer treatment with epothilones

> Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
~ 00293